Souhaitez-vous accéder aux communiqués récents ?

ALISO VIEJO, Calif., Jan. 06, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma™, a late-stage biopharmaceutical company, today announced the appointment of Jean-Frédéric Viret, Ph.D., as the company’s Chief...

ZUG, Switzerland, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Breakthrough Therapy Designation granted to Privosegtor, a neuroprotective candidate, for the treatment of optic neuritisPrivosegtor is advancing...

Accomplished industry leader Robert J. Dempsey brings extensive commercialization and ophthalmic expertise Gary S. Jacob, Ph.D., will transition to Chief Development Officer and continue to serve on...

Dublin, Dec. 15, 2025 (GLOBE NEWSWIRE) -- The "Ophthalmology & Optometry Equipment Market - Global Forecast 2025-2030" has been added to ResearchAndMarkets.com's offering. The evolution of...

MALVERN, Pa., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that...

ANN ARBOR, Mich., Dec. 09, 2025 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...

RetinalGenix signs agreement to hire M. Cory Zwerling as its chief financial officer and interim chief operating officer, effective January 1, 2026

Dublin, Dec. 08, 2025 (GLOBE NEWSWIRE) -- The "Ophthalmology Market - Global Forecast 2025-2030" has been added to ResearchAndMarkets.com's offering.The global ophthalmology market is evolving...

Dublin, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The "U.S. AI-Driven Retinal Screening Device Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been added to ...

Alkeus Pharmaceuticals appoints renowned retina specialist and biotech executive Carlos Quezada-Ruiz, M.D., F.A.S.R.S., as Chief Medical Officer